Ultragenyx Pharmaceutical
RARE
#3251
Rank
S$4.70 B
Marketcap
$48.65
Share price
-4.26%
Change (1 day)
-23.15%
Change (1 year)

Ultragenyx Pharmaceutical (RARE) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : S$1.66 Billion

According to Ultragenyx Pharmaceutical's latest financial reports the company's total liabilities are S$1.66 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Ultragenyx Pharmaceutical - Total liabilities on balance sheet (from 2012 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$1.68 B5.08%
2023-12-31S$1.60 B0.39%
2022-12-31S$1.59 B97.22%
2021-12-31S$0.81 B1.29%
2020-12-31S$0.80 B23.27%
2019-12-31S$0.64 B329.64%
2018-12-31S$0.15 B5.33%
2017-12-31S$0.14 B48.77%
2016-12-31S$96.46 M139.46%
2015-12-31S$40.28 M134.12%
2014-12-31S$17.2 M42.36%
2013-12-31S$12.08 M148.59%
2012-12-31S$4.86 M152.66%
2011-12-31S$1.92 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$1.78 B 7.23%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.79 B-52.38%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.98 B-40.98%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.20 B-87.72%๐Ÿ‡บ๐Ÿ‡ธ USA